PRIA Continues its Support of LSI in 2026

Nancy Bax • November 6, 2025

Continuing and Strengthening our Relationship with a Vital Industry Event

For 2026, PRIA Healthcare continues to be a Supporting Sponsor of LSI’s international events.  MedTech market access, commercialization and investment all take root at these invaluable conferences. PRIA is honored to meet the world's most vibrant innovators, investors, and industry leaders, and to discuss how we can help groundbreaking technologies reach patients who need them most.


Our team, including Jeffrey Sirek, Tonya Dowd, and Stephanie DeFelice, look forward to attending and having meaningful conversations, about navigating the complexities of market access, reimbursement, and commercialization.


If you’re joining us at LSI in 2026, we invite you to connect with us via the partnering app.



See You in Dana Point and Barcelona!

Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, and Market Access (RHEMA) and Corporate Development shared her insights on the importance of early strategic planning on the panel "Unseen Risks, Unlocked Value: Quantifying Regulatory and Reimbursement Barriers in MedTech Investment" at LSI Europe '25.

Tonya Dowd on the informative panel,

Click the Icon below to share this with your network

PRIA's webinar, How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization

Webinar: How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization

July 28, 2026
PRIAs webinar, How Payers Decide: Coverage, Evidence, and Value in MedTech Commercialization featuring Dr. Julie Kessel and Dr. Dot Verbrugge
From Reimbursement to Resource Allocation: How the Rules for Med Tech Adoption are Being Rewritten

Drive, Disruption and Delivery: Strategic Perspectives from a Non-Linear Mind

By Jessica Holmes, MJ • June 30, 2026
From Reimbursement to Resource Allocation: How the Rules for Med Tech Adoption are Being Rewritten
Stop Guessing What FDA Wants by Sam Murray

Reading the Water: Navigating What Matters in Regulatory and Quality

By Sam Murray • June 4, 2026
Stop Guessing What FDA Wants
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough & Beyond

Webinar: Regulatory Meets Reimbursement June 17 2026

June 3, 2026
Regulatory Meets Reimbursement: What MedTech Innovators Need to Know About FDA Breakthrough and Beyond
You Got Your 510(k). Now What?

Cleared for Takeoff: Go-to-Market Insights from a MedTech First Officer

By Suzy Engwall • May 28, 2026
You Got Your 510(k). Now What?
Right Sizing Your Quality System by Sam Murray

Reading the Water: Navigating What Matters in Regulatory and Quality

By Sam Murray, Head of Regulatory & Quality • May 21, 2026
Right Sizing Your Quality System
Cleared for takeoff: Insights from a Medtech First Officer

Cleared for Takeoff: Go-to-Market Insights from a MedTech First Officer

By Suzy Engwall • May 19, 2026
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone

Reading the Water: Navigating What Matters in Regulatory and Quality

By Sam Murray, PRIA • May 14, 2026
Using Regulatory as a Strategy and Not a Milestone
Reading the Water: Navigating What Matters in Regulatory and Quality - Sam Murray, PRIA

Reading the Water: Navigating What Matters in Regulatory and Quality

By Sam Murray, Head of Regulatory & Quality • May 6, 2026
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Medical device strategy CMS/FDA RAPID program

CMS + FDA just announced RAPID. What does this mean for your new device’s pathway?

April 24, 2026
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
MedTech Clinical Evidence Strategy

What CMS's Proposed NTAP Change Means for Your Breakthrough Device Strategy

By PRIA Healthcare • April 20, 2026
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
PRIA Healthcare welcomes Sam Murray as Head of Regulatory and Quality Services

PRIA Healthcare Welcomes Sam Murray as Head of Regulatory and Quality

March 10, 2026
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.